Motivating to Exercise and Diet, and Educating to Healthy Behaviors After Breast Cancer (MEDEA)

This is a phase III randomized controlled trial of a weight loss intervention in breast cancer survivors to reduce fatigue. Having an elevated BMI is a risk factor for cancer-related fatigue, which is the most common symptom during and after cancer treatments. This 12-month weight loss intervention incorporates coaching on diet quality, physical activity, and overall healthy behaviors.

• Sponsor: French National Cancer Institute

• PI/MPI: Inez Vas Louis, MD (PI), Tracy E. Crane, PhD, RDN (Co-I), et al.

• Institution(s): Gustave Roussy, Cancer Campus, Grand Paris

• NCT#: NCT04304924

• Recruiting Status: N/A